Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00116610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Picoplatin as Second-Line Therapy for Subjects With Resistant or Refractory Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase II research study that is designed for patients who have small cell lung cancer (SCLC) that is no longer responding to treatment. Patients will receive picoplatin, a new platinum-based agent that is currently under investigation, in 21-day cycles.
Study identification
- NCT ID
- NCT00116610
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2005 (Type not available)
- Primary completion
- Mar 2007 (Actual)
- Completion
- Mar 2008 (Actual)
- Last update posted
- Jan 21, 2009
2005 – 2008
United States locations
- U.S. sites
- 28
- U.S. states
- 21
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Genesis Cancer Center | Hot Springs | Arkansas | 71913 | — |
| Study Site | Los Angeles | California | — | — |
| Comprehensive Cancer Center | Palm Springs | California | 92262 | — |
| Eastern Connecticut Hematology/Oncology | Norwich | Connecticut | 06360 | — |
| Oncology Hematology Group of South Florida | Miami | Florida | 33176 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Augusta Oncology Associates | Augusta | Georgia | 30901-5104 | — |
| Central Georgia Hematology Oncology Associates | Macon | Georgia | 31201 | — |
| Georgia Cancer Specialists | Tucker | Georgia | 30084 | — |
| Rush Medical College | Chicago | Illinois | 60612-3828 | — |
| Medical Center of Vincennes | Vincennes | Indiana | 47591 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Markey Cancer Center, University of Kentucky | Lexington | Kentucky | 40536 | — |
| The Ochsner Clinic | New Orleans | Louisiana | 70121-2483 | — |
| Louisiana State University Health Science Center | Shreveport | Louisiana | 71130-3932 | — |
| University of Missouri / Ellis Fischel Cancer Center | Columbia | Missouri | 65203-3299 | — |
| The Center for Cancer Care & Research | St Louis | Missouri | 63141 | — |
| Hematology Oncology Centers of the Northern Rockies | Billings | Montana | 59101 | — |
| V.A. Sierra Nevada Health Care | Reno | Nevada | 89502 | — |
| Dartmouth-Hitchcock Medical Center Hematology/Oncology | Lebanon | New Hampshire | 03756 | — |
| Mt. Sinai Medical Center | New York | New York | 10029 | — |
| Southeastern Medical Oncology Center | Goldsboro | North Carolina | 27534-9479 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Consultants in Medical Oncology & Hematology | Drexel Hill | Pennsylvania | 19026 | — |
| South Carolina Oncology Associates, PA | Columbia | South Carolina | 29210 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232-6307 | — |
| Southwest Regional Cancer Center | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00116610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2009 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00116610 live on ClinicalTrials.gov.